⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
ZG Class Notice: Zillow Investors that Suffered Losses are Notified of the Imminent August 10 Securities Class Action Deadline
prnewswire.com
Z
ZG
TSLA
TEVA
Zillow Stock Reminder: Zillow ($Z, $ZG) Investors That Lost Money When Stock Dropped 17% Are Notified of The Upcoming August 10 Securities Class Action Deadline
accessnewswire.com
Z
ZG
RF
TSLA
TEVA
CORRIGE ET REMPLACE : Medincell publie ses résultats financiers annuels consolidés 2025-2026
businesswire.com
TEVA
Medincell Reports FY 2025-26 Annual Results
businesswire.com
TEVA
ABBV
Medincell publie ses résultats financiers annuels consolidés 2025-2026
businesswire.com
TEVA
ABBV
Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy
globenewswire.com
TEVA
Questex’s Fierce Life Sciences Announces the 2026 Partnerships with Sites Summit Agenda
globenewswire.com
LLY
BIIB
AZN
BMY
MRK
TEVA
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
globenewswire.com
ALVO
TEVA
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
globenewswire.com
ALVO
TEVA